BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22212965)

  • 1. One thousand patients with primary myelofibrosis: the mayo clinic experience.
    Tefferi A; Lasho TL; Jimma T; Finke CM; Gangat N; Vaidya R; Begna KH; Al-Kali A; Ketterling RP; Hanson CA; Pardanani A
    Mayo Clin Proc; 2012 Jan; 87(1):25-33. PubMed ID: 22212965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis].
    Chen M; Xu ZF; Xu JQ; Li B; Zhang PH; Qin TJ; Zhang Y; Wang JY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Oct; 37(10):876-880. PubMed ID: 27801320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
    Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
    J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
    Tefferi A; Jimma T; Gangat N; Vaidya R; Begna KH; Hanson CA; Van Dyke DL; Caramazza D; Pardanani A
    Blood; 2011 Oct; 118(17):4595-8. PubMed ID: 21881047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
    Scott BL; Gooley TA; Sorror ML; Rezvani AR; Linenberger ML; Grim J; Sandmaier BM; Myerson D; Chauncey TR; Storb R; Buxhofer-Ausch V; Radich JP; Appelbaum FR; Deeg HJ
    Blood; 2012 Mar; 119(11):2657-64. PubMed ID: 22234678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic risk models for transplant decision-making in myelofibrosis.
    Hernández-Boluda JC; Pereira A; Correa JG; Alvarez-Larrán A; Ferrer-Marín F; Raya JM; Martínez-López J; Velez P; Pérez-Encinas M; Estrada N; García-Gutiérrez V; Fox ML; Payer A; Kerguelen A; Cuevas B; Durán MA; Ramírez MJ; Gómez-Casares MT; Mata-Vázquez MI; Mora E; Gómez M; Cervantes F
    Ann Hematol; 2018 May; 97(5):813-820. PubMed ID: 29396714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A
    Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
    Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
    Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations and prognosis in primary myelofibrosis.
    Vannucchi AM; Lasho TL; Guglielmelli P; Biamonte F; Pardanani A; Pereira A; Finke C; Score J; Gangat N; Mannarelli C; Ketterling RP; Rotunno G; Knudson RA; Susini MC; Laborde RR; Spolverini A; Pancrazzi A; Pieri L; Manfredini R; Tagliafico E; Zini R; Jones A; Zoi K; Reiter A; Duncombe A; Pietra D; Rumi E; Cervantes F; Barosi G; Cazzola M; Cross NC; Tefferi A
    Leukemia; 2013 Sep; 27(9):1861-9. PubMed ID: 23619563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).
    Passamonti F; Cervantes F; Vannucchi AM; Morra E; Rumi E; Pereira A; Guglielmelli P; Pungolino E; Caramella M; Maffioli M; Pascutto C; Lazzarino M; Cazzola M; Tefferi A
    Blood; 2010 Mar; 115(9):1703-8. PubMed ID: 20008785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.
    Tefferi A; Mudireddy M; Gangat N; Hanson CA; Ketterling RP; Pardanani A; Nagorney DM
    Am J Hematol; 2017 Nov; 92(11):1187-1192. PubMed ID: 28782256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.
    Pardanani A; Finke C; Abdelrahman RA; Lasho TL; Tefferi A
    Am J Hematol; 2013 Apr; 88(4):312-6. PubMed ID: 23450619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of Primary Myelofibrosis in the Genomic Era.
    Bose P; Verstovsek S
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S105-13. PubMed ID: 27521306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for leukemic transformation in patients with primary myelofibrosis.
    Huang J; Li CY; Mesa RA; Wu W; Hanson CA; Pardanani A; Tefferi A
    Cancer; 2008 Jun; 112(12):2726-32. PubMed ID: 18404742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostication in primary myelofibrosis.
    Cervantes F; Pereira A
    Curr Hematol Malig Rep; 2012 Mar; 7(1):43-9. PubMed ID: 22072485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the prognostic value of MIPSS70-plus in Chinese patients with primary myelofibrosis].
    Yan X; Li B; Qin TJ; Qu SQ; Pan LJ; Wu JY; Liu D; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Jan; 42(1):15-20. PubMed ID: 33677863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.